Investigation on the cardiovascular effects of aprindine.
D000814:Aniline Compounds; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001011:Aorta; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003864:Depression, Chemical; D004048:Diethylamines; D004285:Dogs; D004562:Electrocardiography; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D007189:Indans / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D007192:Indenes / Q000494:pharmacology*; D007275:Injections, Intravenous; D007773:Lactates / Q000494:pharmacology; D009921:Metaproterenol / Q000494:pharmacology; D014655:Vascular Resistance / Q000187:drug effects
D000814:Aniline Compounds; D000889:Anti-Arrhythmia Agents; D004048:Diethylamines; D007189:Indans; D007192:Indenes; D007773:Lactates; D009921:Metaproterenol